Remedy Robotics Raises $62M Series B for AI-Enabled Robotic Intervention Platform
This story is from 2026-11-16. It is preserved in the archive; the latest stories are on the live feed.
Remedy Robotics announced on November 16, 2026 a $62 million Series B round to advance clinical development and planned deployment of N1, its AI-enabled robotic platform for cardiovascular and neurovascular procedures, toward clinical trials and potential FDA approval.
Read the full story at Unite.AI ↗
Timeline · 2 reports
- 2026-11-17 09:36 · AI Insider
Remedy Robotics Raises $62M in Series B Funding to Advance AI-Enabled Vascular Intervention System - 2026-11-16 15:30 · Unite.AI
Remedy Robotics Raises $62M Series B to Advance AI Cardiovascular Care